Home / 2015 / February (page 9)

Monthly Archives: February 2015

Does ICP Impact on Glucose Tolerance, Dyslipidemia and Fetal Growth in Pregnancy?

Researchers measured the changes in glucose and lipid concentrations in women with intrahepatic cholestasis of pregnancy (ICP) and studied the influence on fetal growth…. A team of British and American researchers conducted a prospective study comparing metabolic outcomes in cholestastic and uncomplicated singleton pregnancies at two university hospitals in the …

Read More »

Preventing Duplicate Test Orders Reduces Costs

Unnecessary laboratory tests can be reduced by blocking physicians from ordering the same test for hospitalized patients more than once a day. A new program at Cleveland Clinic employed a clinical decision support tool to block duplicate test orders during the computerized physician order entry process each day and to …

Read More »

Reducing Fructose Intake Could Reduce Diabetes-related Morbidity

James J. DiNicolantonio, PharmD, of Saint Luke’s Mid America Heart Institute in Kansas City, Mo stated that reducing intake of added fructose and other added sugars could reduce diabetes-related morbidity. He added that added fructose increases risk of diabetes, diabetes-related metabolic abnormalities, and cardiovascular issues. In contrast, whole foods containing …

Read More »

Diabetic Foot Ulcers Linked to Premature Death

Individuals with diabetic foot ulcers were shown to be at greater risk of premature death from vascular and nonvascular causes than those without ulcers, in a recent study. Researchers obtained data for patients who attended a secondary care diabetic foot clinic or a general diabetes clinic between 2009 and 2010. …

Read More »

FDA Approves Empagliflozin/Linagliptin Combo (Glyxambi) for Type 2

The Boehringer Ingelheim/Eli Lilly and Company combination SGLT2 inhibitor and DPP-4 inhibitor Glyxambi has been approved by the FDA. The empagliflozin/linagliptin combo is approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes when neither of the individual components are working as …

Read More »

Letter from the Editor, #767

I was working in the pharmacy and my technician attempted to process a prescription for a 71 y/o patient for glyburide 5 mg. The claim kept rejecting as "drug not covered, prior authorization requested." This made no sense to her or the intern as it is a cheap generic medication. …

Read More »

Editor’s Note, DCMS #226

Today I was working with two patients to convert them from sliding scale and mixed insulin to basal/bolus dosing. As I was going over the reasons for making the change and the responsibilities they would have, we got stuck at glucose monitoring. I finally got their attention when I told …

Read More »

Practical Diabetes Care, 3rd Ed., Excerpt #1: Diabetes in the Emergency Department

alt

David Levy, MD, FRCP INTRODUCTION Every day many patients with established or newly diagnosed diabetes pass through emergency departments. Few require admission, but all need careful evaluation and management: emergencies in diabetes can develop rapidly, and they carry a risk of mortality. Deciding who needs admission requires clinical skill and experience. …

Read More »